Honey as a mood booster? small study tests stingless bee honey for depression
NCT ID NCT06723249
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether taking stingless bee honey daily for two months could improve depression symptoms, memory, and stress markers in adults with major depressive disorder. 45 participants either took the honey or nothing (no placebo). Researchers measured mood, blood markers, and verbal memory. The goal was to see if honey could be a helpful add-on to standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- stingless bee honey
- What this could lead to
- If it works, this could point toward a natural supplement to help ease depression symptoms and improve memory.
- What could go wrong
- This is a small, completed trial with no placebo, so results may be unreliable. The honey is a supplement, not a replacement for standard depression treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
45 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults with ages 18 to 65 * with Major Depressive Disorder with scores of Beck Depression Inventory Malay version equal or more than 11 Exclusion Criteria: * Women in pregnancy or breast-feeding. * Patients who with honey allergy or stingless bee honey allergy. * Currently taking honey not limited to stingless bee honey or taken honey not limited to stingless bee honey in the past one month. * comorbidity either with generalized anxiety disorder, * panic disorder, * social anxiety disorder, * bipolar disorder, * substance-use disorder, * suicidal ideation or attempt, * dementia, * Alzheimer disease, * diabetic, * hypertension, * chronic kidney disease
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Major depressive disorder (MDD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universiti Sains Malaysia
Kubang Kerian, Kelantan, 16150, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a structured care pathway lift teen depression in primary care?
- Can Anti-Inflammatory drugs lift depression that Won't budge?
- A brain stimulation trial aims to rewire the circuit behind depression
- Can pairing ketamine with talk therapy beat depression alone?
- Genetic matchmaking for antidepressants: a global trial puts personalization to the test
- Could a common vitamin lift depression in young people?